Literature DB >> 16303872

Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).

Anubha Gupta1, Pierre Chatelain, Roy Massingham, E Niclas Jonsson, Margareta Hammarlund-Udenaes.   

Abstract

The objective of this study was to compare the blood-brain barrier (BBB) transport and brain distribution of levo- (R-CZE) and dextrocetirizine (S-CZE). Microdialysis probes, calibrated using retrodialysis by drug, were placed into the frontal cortex and right jugular vein of eight guinea pigs. Racemic CZE (2.7 mg/kg) was administered as a 60-min i.v. infusion. Unbound and total concentrations of the enantiomers were measured in blood and brain with liquid chromatography-tandem mass spectrometry. The brain distribution of the CZE enantiomers were compared using the parameters K(p,) K(p,u,) K(p,uu), and V(u,br). K(p) compares total brain concentration to total plasma concentration, K(p,u) compensates for binding in plasma, whereas K(p,uu) also compensates for binding within the brain tissue and directly quantifies the transport across the BBB. V(u,br) describes binding within the brain. The stereoselective brain distribution indicated by the K(p) of 0.22 and 0.04 for S- and R-CZE, respectively, was caused by different binding to plasma proteins. The transport of the CZE enantiomers across the BBB was not stereoselective, since the K(p,uu) was 0.17 and 0.14 (N.S.) for S- and R-CZE, respectively. The K(p,uu) values show that the enantiomers are effluxed to a large extent across the BBB. The V(u,br) of approximately 2.5 ml/g brain was also similar for both the enantiomers, and the value indicates high binding to brain tissue. Thus, when determining stereoselectivity in brain distribution, it is important to study all factors governing this distribution, binding in blood and brain, and the BBB equilibrium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303872     DOI: 10.1124/dmd.105.007211

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  31 in total

1.  In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes.

Authors:  Annika Lindqvist; Jaap Rip; Joan van Kregten; Pieter J Gaillard; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2015-08-15       Impact factor: 4.200

2.  Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.

Authors:  Nathan D Pfeifer; Kevin B Harris; Grace Zhixia Yan; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-08-29       Impact factor: 3.922

Review 3.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

4.  Improved measurement of drug exposure in the brain using drug-specific correction for residual blood.

Authors:  Markus Fridén; Helena Ljungqvist; Brian Middleton; Ulf Bredberg; Margareta Hammarlund-Udenaes
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

5.  Determination of the unbound fraction of R- and S-methadone in human brain.

Authors:  Karen M D Holm; Kristian Linnet
Journal:  Int J Legal Med       Date:  2016-04-07       Impact factor: 2.686

6.  Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery.

Authors:  Irena Loryan; Vikash Sinha; Claire Mackie; Achiel Van Peer; Wilhelmus Drinkenburg; An Vermeulen; Denise Morrison; Mario Monshouwer; Donald Heald; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

7.  Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.

Authors:  Shana Jacobs; Cynthia L McCully; Robert F Murphy; John Bacher; Frank M Balis; Elizabeth Fox
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-07       Impact factor: 3.333

Review 8.  Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.

Authors:  Stina Syvänen; Jonas Eriksson
Journal:  ACS Chem Neurosci       Date:  2012-12-04       Impact factor: 4.418

Review 9.  In vitro, in vivo and in silico models of drug distribution into the brain.

Authors:  Scott G Summerfield; Kelly C Dong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-13       Impact factor: 2.745

10.  Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice.

Authors:  Shigeo Miyata; Shoko Hirano; Masahiro Ohsawa; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.